| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Biochemistry and Pediatrics, Schools of Medicine and Dentistry, State University of New York at Buffalo, Buffalo New York
R5020 (17,21-dimethyl-19-nor-4,9-pregnadiene-3,20-dione), a synthetic progestin, was tested for its binding to purified human transcortin, albumin and human serum. Scatchard analysis showed that R5020 bound relatively weakly to transcortin (Kass= 8x106M–1); in 20% human serum or albumin greater than 90%was bound with low Kass and an indeterminate number of binding sites.
Supported in part by U.S.P.H.S. grant GM21045.
Received October 20, 1976.
This article has been cited by other articles:
![]() |
M Ip, R. Milholland, F Rosen, and U Kim Mammary cancer: selective action of the estrogen receptor complex Science, January 26, 1979; 203(4378): 361 - 363. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |